MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/ajhp/zxae068

Медицинская библиотека · American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2024

Analysis of appropriateness and safety when discharging patients on triple-antithrombotic therapies.

Robichaux Taylor, Edwards Kristyn, Carter Ashley, Washington Andrea, Brooks Shelby

Оценочное исследованиеСтатьяПеревод в очереди

Аннотация

PURPOSE: To analyze the appropriateness of triple-antithrombotic therapy based on the 2020 American College of Cardiology (ACC) consensus statement while evaluating safety outcomes for patients with respect to adverse events.

METHODS

A single-center, retrospective chart review was conducted using electronic medical records from December 18, 2020, to August 31, 2022. The primary endpoint was the rate of appropriateness for triple-antithrombotic therapy in patients discharged from Ochsner LSU Health Shreveport. Appropriateness was a composite endpoint extrapolated from the 2020 ACC consensus statement. For therapy to be defined as appropriate, patients had to have had the correct therapy indication, medications, dosing, and 30-day duration. Secondary safety endpoints included the percentage of patients rehospitalized at 14 and 30 days, the rate of major bleeding events, and the percentage of patients on gastrointestinal prophylaxis while on triple-antithrombotic therapy.

RESULTS

A total of 93 patients were included in the study, of whom 31 (33%) received appropriate triple-antithrombotic therapy. Prolonged duration of triple-antithrombotic therapy was the most common reason that therapy did not meet the primary endpoint. The readmission rate due to bleeding was 2.2% at 14 days and 6.5% at 30 days. Within 30 days of initiation of triple therapy, 4.3% of patients endured major bleeding as defined by the International Society on Thrombosis and Hemostasis and 2 patients died.

CONCLUSION

In this single-center study, triple-antithrombotic therapy appropriately adhered to the 2020 ACC consensus statement for one-third of patients discharged on this therapy.

Для цитирования: Robichaux Taylor, Edwards Kristyn, Carter Ashley, Washington Andrea, Brooks Shelby. Analysis of appropriateness and safety when discharging patients on triple-antithrombotic therapies.. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2024. DOI: 10.1093/ajhp/zxae068.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.